Fluid restriction and prophylactic indomethacin in extremely low birth weight infants

Area of Science:

• Neonatal medicine
• Pediatric pulmonology
• Clinical research

Background:

• Bronchopulmonary dysplasia (BPD) remains a significant challenge in extremely low birth weight (ELBW) infants despite improved survival rates.
• Indomethacin prophylaxis offers short-term benefits but does not impact long-term outcomes or BPD rates.
• The potential synergistic effect of fluid restriction with indomethacin warrants investigation.

Purpose of the Study:

• To evaluate the impact of a fluid restriction policy, alongside indomethacin prophylaxis, on morbidity and mortality in ELBW infants.
• To compare outcomes between ELBW infants receiving combined fluid restriction and indomethacin versus indomethacin alone.

Main Methods:

• A systematic review was planned using standard Cochrane Neonatal Review Group search strategies across major databases (MEDLINE, EMBASE, CENTRAL).
• Inclusion criteria focused on randomized or quasi-randomized trials comparing fluid restriction plus indomethacin with indomethacin prophylaxis alone in ELBW infants.
• Methodological quality assessment and planned statistical analysis using Review Manager 5 were outlined.

Main Results:

• No randomized controlled trials were identified that specifically investigated the combined effect of fluid restriction and indomethacin prophylaxis versus indomethacin alone in ELBW infants.
• The review could not provide evidence on the interaction between these interventions.

Conclusions:

• A significant knowledge gap exists regarding the combined efficacy of fluid restriction and indomethacin prophylaxis in ELBW infants.
• A well-designed randomized controlled trial is essential to determine if this combined policy improves long-term survival and reduces neurodevelopmental impairments.